201
Participants
Start Date
November 21, 2017
Primary Completion Date
November 19, 2021
Study Completion Date
November 19, 2021
Abilify maintena
Switching from oral atypical antipsychotics to long-acting injectable aripiprazole (Abilify maintena)
Yong-In Mental Hospital, Yongin-si
Inha University Hospital, Incheon
Konkuk University Chungju Hospital, Chungju
Gongju National Hospital, Gongju
Eulji University Hospital, Daejeon
Konyang University Hospital, Daejeon
Jeju National University Hospital, Jeju City
Hanyang University Guri Hospital, Guri-si
Cha Bundang Medical Center, Seongnam-si
Seoul National University Bundang Hospital, Seongnam-si
The Catholic University of Korea Uijeongbu ST. Mary'S Hospital, Uijeongbu-si
Chonbuk National University Hospital, Jeonju
Keimyung University Dongsan Medical Center, Daegu
Kyungpook National University Hospital, Daegu
Yeungnam University Medical Center, Daegu
Chungnam National University Hospital, Daejeon
Chonnam National University Hospital, Gwangju
International St. Mary's Hospital, Incheon
Inje University Haeundae Paik Hospital, Pusan
Pusan National University Yangsan Hospital, Pusan
Eulji General Hospital, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Korea University Anam Hospital, Seoul
Kyung Hee University Hospital, Seoul
Seoul National University Hosipital, Seoul
Kangbuk Samsung Hospital, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
INDUSTRY